Execute 25-30% defensive trim into $352-354, hard stop at $338, preserve structural position
The bear case is real and worsening (MACD histogram at -1.27 is the worst reading in our decision history), but the franchise floor is also real (17.8% ROE, $33B buyback, 10% buffer to 200 SMA, positive Q3 optionality from Petno pre-announcement). Trim tactically, preserve structurally, execute into $352-354 (not $356) for realistic fill, and size to the lower bound (25-30%) per the explicit lesson calibration from 9/15 and 9/16 reflections.
| Position | Action |
|---|---|
| Into $352-354 zone (50 SMA retest / 10 EMA confluence) | ~12-15% trim (Tranche 1) |
| Close below $347.99 on volume >10M OR 5 trading sessions, whichever fires first | ~12-15% trim (Tranche 2) |
| Residual position (70-75%) | Hard stop at $338 closing basis (two ATR below current, respects pre-Q3 implied volatility expansion) |
JPMorgan's pullback to the lower Bollinger Band represents a textbook mid-trend reloading opportunity in a world-class compounding franchise, supported by accelerating Q3 guidance pre-announced by management, a 10% dividend hike signaling balance-sheet strength, and a ~5.5% total shareholder yield at a justified 2.63x P/B premium.
| Indicator | Value | Signal |
|---|---|---|
| Close | 349.31 | neutral |
| 10 EMA | 352.70 | bearish |
| 50 SMA | 352.92 | bearish |
| 200 SMA | 318.48 | bullish |
| RSI (14) | 43.92 | neutral |
| MACD | -0.63 | bearish |
| MACD Signal | 0.64 | bearish |
| MACD Histogram | -1.27 | bearish |
| BOLL Upper | 361.14 | neutral |
| BOLL Middle | 354.57 | neutral |
| BOLL Lower | 347.99 | neutral |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Close $318-322 (200 SMA) with bullish reversal candle and positive MACD histogram turn
Then: 10-12% structural rebuild
The $1.50→$1.65 dividend hike (10% raise) combined with $8.79B in Q2 buybacks delivers ~5.5% total shareholder yield — not a low-yielding bank but a yield instrument with operating leverage.
↩ rebuts: “Bear's characterization of 1.72% dividend yield as 'low'”
EV: $365-370 on Q3 print (from entry at $344-348) · concedes: The technical setup requires the lower Bollinger Band at $347.99 to hold on a closing basis — if BOLL lower fails, re-evaluate; Q2 did benefit from a ~$4.4B one-time CECL reserve release (though normalized earnings still grew 18.6% YoY); The 2.63x P/B is historically rich for a bank (though justified by 17.79% ROE vs. 10-13% sector norm); Goldman Sachs is experiencing trading weakness, which could indicate broader sector headwinds; The 200 SMA at $318 is the hard invalidation line if the long-term uptrend breaks
JPM is a high-quality bank at a dangerous entry point — trading near 52-week highs with breaking technicals, peak-cycle ROE flattered by one-time reserve releases, and exposed to stagflationary macro headwinds — making the risk/reward asymmetry overwhelmingly unfavorable.
· concedes: JPM is a high-quality bank franchise with genuine competitive moat; The stock will not necessarily hit bear case targets — upside invalidation is sustained close above $356 with MACD histogram contracting positive
→ vs conservative: The '200 SMA at $318 being held up' and 'long-term uptrend intact' thesis buys nothing but the right to watch position bleed from $349 toward $343, then $335 while the 200 SMA sits 10% below current price; this is 'hope dressed up as analysis'
→ vs conservative: Conservative's own technical report says 'Trim risk, don't exit' but then argues against the trade; the trader is doing exactly what the technical report recommends
→ vs neutral: The 'wait for $320-340' thesis is broken because most investors lack discipline to actually pull the trigger when tape is falling and end up buying higher on recovery or freezing entirely
→ vs neutral: ROE of 17.8% and dividend hike to $1.65 are being used to justify 2.63x P/B at peak-cycle earnings power in stagflationary macro where zero Fed cuts are priced at 95% probability
→ vs conservative: Conservative wants investor 'frozen waiting for confirmation' while the trader is 'taking the shot that's actually there'
→ vs neutral: 'Perfect entry timing' is 'the most seductive trap in all of finance' and the suggestion to wait assumes discipline most investors don't have
→ vs conservative: 'One bad session, one Iran headline, one hawkish Fed whisper' and the lower Bollinger Band fails on a closing basis; once it does, next support isn't until $343 then vacuum to $335
→ vs neutral: Q2 earnings were flattered by one-time $4.4 billion special credit; stripping that out reveals $17.78 billion and the 'accelerating growth' narrative loses jet fuel
→ vs conservative: MACD bearish crossover is 'not a yellow flag' but 'a momentum regime change happening in real time'
→ vs neutral: 'Goldman weakness means JPM gains share' narrative is broken because sector revenue pool is contracting, creating harder comparable for JPM's record quarter against softening tape
| ATR (14) | 6.92 | neutral |
| VWMA | 353.78 | bearish |
| Day Range Low | 345.28 | neutral |
| Day Range High | 353.49 | neutral |
Support: 347.99 · 343.07 · 318.48 | Resistance: 354.57 · 361.14 · 365.18
JPM is in a long-term uptrend (price 9.7% above 200 SMA at 318.48) but undergoing a near-term corrective pullback after losing both the 10 EMA (352.70) and 50 SMA (352.92). MACD has issued a fresh bearish crossover with histogram expanding to -1.27. Price closed at 349.31 near the lower Bollinger Band (347.99), suggesting further downside risk but not yet a breakdown. Immediate support sits at 347.99 (BOLL lower), with next support at 343.07; resistance at 354.57 (BOLL middle) and 352.70/352.92 (reclaimed pivot). RSI at 43.92 is neutral-weak with room to fall. VWMA declining from 359 to 353.78 suggests mild distribution. Overall bias is HOLD: maintain core long-term exposure but trim risk; avoid new longs until price reclaims 352.70/352.92 and MACD histogram contracts toward zero.
Market Cap
$928.5 B
P/E (TTM)
14.97x
Forward P/E
13.98x
PEG Ratio
1.62
Price / Book
2.63x
EPS (TTM)
$23.34
Forward EPS
$24.99
Dividend Yield
1.72%
Beta
0.975
Operating Margin
50.4%
Net Profit Margin
34.9%
Return on Equity (ROE)
17.79%
Return on Assets (ROA)
1.36%
Book Value / Share
$133.01
Total Revenue (Q2 2026)
$52.85 B
Net Income (Q2 2026)
$21.16 B
Normalized Net Income (Q2 2026)
$17.78 B
Diluted EPS (Q2 2026)
$7.70
Net Interest Income (Q2 2026)
$25.51 B
Total Assets
$5.015 T
Net Loans
$1.516 T
Common Equity
$353.6 B
Tangible Book Value
$289.3 B
Diluted Shares Outstanding
2,694 M
Buybacks (Q2 2026)
$8.79 B
Dividends (Q2 2026)
$4.34 B
Total Shareholder Yield
~5.5%
52-Week High
$366.50
52-Week Low
$279.10
50-Day MA
$352.54
200-Day MA
$320.15
Strengths
Concerns
JPMorgan Chase posted Q2 2026 revenue of $52.85B (+17.7% YoY) with net income of $21.16B boosted by a $4.39B one-time special credit; excluding this item, normalized earnings of $17.78B still delivered +18.6% YoY growth. The bank maintains exceptional profitability metrics (17.79% ROE, 50.4% operating margin) and returns approximately $13.1B quarterly to shareholders, equating to a 5.5% total yield through dividends and buybacks. However, shares trade near 52-week highs at a premium P/B of 2.63x, with the Q2 beat dependent on a non-recurring reserve release — Q3 2026 results will be critical to confirm underlying 15-18% normalized earnings growth can be sustained.
Macro: Fed funds path: 95% probability of ZERO cuts in 2026 (Polymarket, $8.4M volume, +2.5pp week-over-week hardening toward no cuts); Recession odds: 10% (+2.0pp past week); "Higher for longer" rate regime with Polymarket pricing HOLD or even HIKE; Oil near $100 from Iran conflict creating stagflationary impulse; 10-year Treasury yield easing alongside oil pullback on 9/17; Long-end yield relief providing modest bond rally. Note: FRED macro data unavailable (missing FRED_API_KEY); macro readings reconstructed from prediction markets and corroborating news.